ISO 10993-3:2026

Current Revision
Biological evaluation of medical devices - Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity

Best Price Guarantee Aug 1, 2026 English 48 Pages

Sub Total (1 Item(s)) $ 0.00
Estimated Shipping $ 0.00
Total (Pre-Tax) $ 0.00
View in Library
or
International Organization for Standardization Logo

Biological evaluation of medical devices - Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity

PUBLISH DATE 2026

This document specifies strategies for risk estimation and evaluation of biological harms with respect to:

  • genotoxicity;
  • carcinogenicity;
  • reproductive toxicity; and
  • developmental toxicity.

This document is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity has been established.

This document is not applicable to active pharmaceutical ingredients of device-drug combination products or biological components of device-biologic combination products which are covered by regulations.

NOTE Guidance on selecting relevant biological effects for medical devices is covered in ISO 10993-1.

Loading...

Failed to load document history.

Publish Date Document Id Type View